You just read:

Bionical Emas and Jazz Pharmaceuticals Enter into an Agreement for Expanded Access to Lurbinectedin in Relapsed Small Cell Lung Cancer in the United States

News provided by

Bionical Emas and Jazz Pharmaceuticals

11 May, 2020, 13:30 BST